Haven’t had the chance to catch up on what’s been going on in the dental industry? In this week’s Dental Industry Summary, we cover a new review linking common medications to bad breath, how enriched artificial saliva could protect cancer patients' teeth and more.
A recent review published in the International Dental Journal highlights that various common medications, including antifungals, nonsteroidal anti-inflammatory drugs (NSAIDs), and ranitidine, may contribute to halitosis. Analyzing literature from 2015 to 2024, researchers from the University of Toronto identified both intra-oral and extra-oral causes, noting that drugs like cysteamine and certain tumor inhibitors can lead to bad breath through gastrointestinal side effects or the exhalation of odorous metabolites. The authors emphasize that understanding these pharmaceutical links is crucial for clinicians to accurately diagnose and effectively manage the underlying causes of a patient's bad breath.
Enriched artificial saliva may protect teeth in cancer patients
Enriched artificial saliva has been found to potentially protect the teeth of cancer patients, who often suffer from dry mouth due to treatments like chemotherapy and radiation. This condition can lead to increased dental issues, and the use of enhanced artificial saliva could help mitigate these effects by providing necessary moisture and protective elements to the oral environment.
-May-05-2025-09-27-42-7436-PM.png?width=200&height=41&name=sikka-ai-logo%20(1)-May-05-2025-09-27-42-7436-PM.png){kind=small}
v
